Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
15,524,823
-
Shares change
-
+2,564,650
-
Total reported value, excl. options
-
$2,422,618,787
-
Value change
-
+$357,006,384
-
Put/Call ratio
-
183%
-
Number of buys
-
106
-
Number of sells
-
86
-
Price
-
$156.00
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q4 2014
As of 31 Dec 2014 INTERCEPT PHARMACEUTICALS IN - COM (ICPT) had 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,524,823 shares of stock of the company.
Largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, Carmignac Gestion, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Capital World Investors, JENNISON ASSOCIATES LLC, MILLENNIUM MANAGEMENT LLC, COLUMBIA WANGER ASSET MANAGEMENT LLC, and BlackRock Fund Advisors.
This table shows 168 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.